Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.
Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification…
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.
cGMP Deviations: Products may have microbial contamination.
CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.
BMW of North America, LLC (BMW) is recalling certain 2018-2019 X3 sDrive30i, xDrive30i and M40i and 2019 X4 xDrive30i and M40i vehicles. The front seatback frames may have been improperly…
Mazda North American Operations (Mazda) is recalling certain 2019 Mazda3 vehicles equipped with manual dimming mirrors. The adhesive between the interior rearview mirror and the housing may…
Chrysler (FCA US LLC) is recalling certain 2019 Ram 1500 vehicles. The instrument cluster may not properly illuminate driver warnings. As such, these vehicles fails to conform with the…
The products have been confirmed to have reduced or no additive within the tube reservoir. The tubes may develop visible clots within the tube samples or micro clots that are not easily…
Potential for failed stability antimicrobial effectiveness testing.
Browse recent months with enough recall history for useful comparison.
